These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 10072077)

  • 1. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells.
    Moriggl R; Topham DJ; Teglund S; Sexl V; McKay C; Wang D; Hoffmeyer A; van Deursen J; Sangster MY; Bunting KD; Grosveld GC; Ihle JN
    Immunity; 1999 Feb; 10(2):249-59. PubMed ID: 10072077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction.
    Nakajima H; Liu XW; Wynshaw-Boris A; Rosenthal LA; Imada K; Finbloom DS; Hennighausen L; Leonard WJ
    Immunity; 1997 Nov; 7(5):691-701. PubMed ID: 9390692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-2-mediated cell cycle progression and inhibition of apoptosis does not require NF-kappa B or activating protein-1 activation in primary human T cells.
    Iacobelli M; Rohwer F; Shanahan P; Quiroz JA; McGuire KL
    J Immunol; 1999 Mar; 162(6):3308-15. PubMed ID: 10092783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific inhibition of Stat5a/b promotes apoptosis of IL-2-responsive primary and tumor-derived lymphoid cells.
    Behbod F; Nagy ZS; Stepkowski SM; Karras J; Johnson CR; Jarvis WD; Kirken RA
    J Immunol; 2003 Oct; 171(8):3919-27. PubMed ID: 14530308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.
    Nagy ZS; Wang Y; Erwin-Cohen RA; Aradi J; Monia B; Wang LH; Stepkowski SM; Rui H; Kirken RA
    J Leukoc Biol; 2002 Oct; 72(4):819-28. PubMed ID: 12377952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
    Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
    J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential role of Stat5 for IL-5-dependent IgH switch recombination in mouse B cells.
    Horikawa K; Kaku H; Nakajima H; Davey HW; Hennighausen L; Iwamoto I; Yasue T; Kariyone A; Takatsu K
    J Immunol; 2001 Nov; 167(9):5018-26. PubMed ID: 11673510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective IL-2-mediated IL-2 receptor alpha chain expression in Stat3-deficient T lymphocytes.
    Akaishi H; Takeda K; Kaisho T; Shineha R; Satomi S; Takeda J; Akira S
    Int Immunol; 1998 Nov; 10(11):1747-51. PubMed ID: 9846704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadd45gamma is dispensable for normal mouse development and T-cell proliferation.
    Hoffmeyer A; Piekorz R; Moriggl R; Ihle JN
    Mol Cell Biol; 2001 May; 21(9):3137-43. PubMed ID: 11287618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restricted STAT5 activation dictates appropriate thymic B versus T cell lineage commitment.
    Goetz CA; Harmon IR; O'Neil JJ; Burchill MA; Johanns TM; Farrar MA
    J Immunol; 2005 Jun; 174(12):7753-63. PubMed ID: 15944278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells.
    Moriggl R; Sexl V; Piekorz R; Topham D; Ihle JN
    Immunity; 1999 Aug; 11(2):225-30. PubMed ID: 10485657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin and interleukin-2 receptors in T lymphocytes signal through a MGF-STAT5-like transcription factor.
    Gouilleux F; Moritz D; Humar M; Moriggl R; Berchtold S; Groner B
    Endocrinology; 1995 Dec; 136(12):5700-8. PubMed ID: 7588326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT5 is required for thymopoiesis in a development stage-specific manner.
    Kang J; DiBenedetto B; Narayan K; Zhao H; Der SD; Chambers CA
    J Immunol; 2004 Aug; 173(4):2307-14. PubMed ID: 15294943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules.
    Chida D; Wakao H; Yoshimura A; Miyajima A
    Mol Endocrinol; 1998 Nov; 12(11):1792-806. PubMed ID: 9817603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncoupling of promitogenic and antiapoptotic functions of IL-2 by Smad-dependent TGF-beta signaling.
    Nelson BH; Martyak TP; Thompson LJ; Moon JJ; Wang T
    J Immunol; 2003 Jun; 170(11):5563-70. PubMed ID: 12759434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-2 and IL-7 induce heterodimerization of STAT5 isoforms in human peripheral blood T lymphoblasts.
    Rosenthal LA; Winestock KD; Finbloom DS
    Cell Immunol; 1997 Nov; 181(2):172-81. PubMed ID: 9398404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses.
    Teglund S; McKay C; Schuetz E; van Deursen JM; Stravopodis D; Wang D; Brown M; Bodner S; Grosveld G; Ihle JN
    Cell; 1998 May; 93(5):841-50. PubMed ID: 9630227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of cytokine differential induction of STAT complexes in primary human T and NK cells.
    Yu CR; Young HA; Ortaldo JR
    J Leukoc Biol; 1998 Aug; 64(2):245-58. PubMed ID: 9715265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway.
    Santos SC; Lacronique V; Bouchaert I; Monni R; Bernard O; Gisselbrecht S; Gouilleux F
    Oncogene; 2001 Apr; 20(17):2080-90. PubMed ID: 11360192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells.
    Nosaka T; Kawashima T; Misawa K; Ikuta K; Mui AL; Kitamura T
    EMBO J; 1999 Sep; 18(17):4754-65. PubMed ID: 10469654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.